HIVE Fundamental Analysis - HIVE DIGITAL TECHNOLOGIES LT

Fundamental Rating

Taking everything into account, HIVE scores 5 out of 10 in our fundamental rating. HIVE was compared to 281 industry peers in the Software industry. The financial health of HIVE is average, but there are quite some concerns on its profitability. HIVE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HIVE was profitable.

HIVE had a positive operating cash flow in the past year.

In multiple years HIVE reported negative net income over the last 5 years.

Each year in the past 5 years HIVE had a positive operating cash flow.

1.2 Ratios

HIVE's Return On Assets of 4.57% is fine compared to the rest of the industry. HIVE outperforms 71.53% of its industry peers.

The Return On Equity of HIVE (5.13%) is better than 69.04% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.57%
ROE	5.13%
ROIC	N/A

ROA(3y)-37.49%

ROA(5y)-16.27%

ROE(3y)-49.77%

ROE(5y)-22%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HIVE's Profit Margin of 22.36% is amongst the best of the industry. HIVE outperforms 87.90% of its industry peers.

The Operating Margin and Gross Margin are not available for HIVE so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	22.36%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for HIVE has been increased compared to 1 year ago.

Compared to 5 years ago, HIVE has more shares outstanding

Compared to 1 year ago, HIVE has an improved debt to assets ratio.

2.2 Solvency

HIVE has an Altman-Z score of 8.72. This indicates that HIVE is financially healthy and has little risk of bankruptcy at the moment.

HIVE's Altman-Z score of 8.72 is amongst the best of the industry. HIVE outperforms 81.49% of its industry peers.

HIVE has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.03, HIVE is in the better half of the industry, outperforming 60.50% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	8.72

ROIC/WACCN/A

WACC10.5%

2.3 Liquidity

A Current Ratio of 3.42 indicates that HIVE has no problem at all paying its short term obligations.

HIVE has a Current ratio of 3.42. This is amongst the best in the industry. HIVE outperforms 80.78% of its industry peers.

A Quick Ratio of 3.42 indicates that HIVE has no problem at all paying its short term obligations.

HIVE has a Quick ratio of 3.42. This is amongst the best in the industry. HIVE outperforms 81.49% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.42
Quick Ratio	3.42

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.17% over the past year.

HIVE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.47%.

HIVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.59% yearly.

EPS 1Y (TTM)145.17%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%500%

Revenue 1Y (TTM)4.47%

Revenue growth 3Y-18.07%

Revenue growth 5Y31.59%

Sales Q2Q%41.47%

3.2 Future

Based on estimates for the next years, HIVE will show a very strong growth in Earnings Per Share. The EPS will grow by 78.85% on average per year.

HIVE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 53.13% yearly.

EPS Next Y720.19%

EPS Next 2Y432.1%

EPS Next 3Y78.85%

EPS Next 5YN/A

Revenue Next Year187.08%

Revenue Next 2Y101.53%

Revenue Next 3Y53.13%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 42.88, HIVE can be considered very expensive at the moment.

Based on the Price/Earnings ratio, HIVE is valued a bit cheaper than 63.35% of the companies in the same industry.

HIVE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.86.

With a Price/Forward Earnings ratio of 11.15, the valuation of HIVE can be described as very reasonable.

Based on the Price/Forward Earnings ratio, HIVE is valued cheaper than 93.59% of the companies in the same industry.

Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, HIVE is valued rather cheaply.

		Industry Rank	Sector Rank
PE	42.88
Fwd PE	11.15

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

HIVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as HIVE's earnings are expected to grow with 78.85% in the coming years.

PEG (NY)0.06

PEG (5Y)N/A

EPS Next 2Y432.1%

EPS Next 3Y78.85%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HIVE!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HIVE DIGITAL TECHNOLOGIES LT

NASDAQ:HIVE (10/6/2025, 3:33:08 PM)

5.575

+1.13 (+25.28%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)08-14 2025-08-14/amc

Earnings (Next)11-13 2025-11-13

Inst Owners23.03%

Inst Owner Change0%

Ins Owners0.29%

Ins Owner Change0%

Market Cap1.31B

Analysts80

Price Target4.44 (-20.36%)

Short Float %6.28%

Short Ratio0.53

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)185.32%

Min EPS beat(2)100.9%

Max EPS beat(2)269.73%

EPS beat(4)4

Avg EPS beat(4)130.87%

Min EPS beat(4)43.42%

Max EPS beat(4)269.73%

EPS beat(8)7

Avg EPS beat(8)88.66%

EPS beat(12)9

Avg EPS beat(12)16.46%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)0.88%

Min Revenue beat(2)-1.52%

Max Revenue beat(2)3.29%

Revenue beat(4)2

Avg Revenue beat(4)-0.05%

Min Revenue beat(4)-8.08%

Max Revenue beat(4)6.13%

Revenue beat(8)5

Avg Revenue beat(8)3.67%

Revenue beat(12)9

Avg Revenue beat(12)18.5%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)4.47%

PT rev (3m)-14.09%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-139.95%

EPS NY rev (1m)-46.15%

EPS NY rev (3m)337.46%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)3.71%

Revenue NY rev (1m)7.21%

Revenue NY rev (3m)8.6%

Valuation

		Industry Rank	Sector Rank
PE	42.88
Fwd PE	11.15
P/S	10.2
P/FCF	N/A
P/OCF	43.02
P/B	2.34
P/tB	2.34
EV/EBITDA	N/A

EPS(TTM)0.13

EY2.33%

EPS(NY)0.5

Fwd EY8.97%

FCF(TTM)-0.51

FCFYN/A

OCF(TTM)0.13

OCFY2.32%

SpS0.55

BVpS2.38

TBVpS2.38

PEG (NY)0.06

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	4.57%
ROE	5.13%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	22.36%
GM	N/A
FCFM	N/A

ROA(3y)-37.49%

ROA(5y)-16.27%

ROE(3y)-49.77%

ROE(5y)-22%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.2

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	206.22%
Cap/Sales	116.51%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.42
Quick Ratio	3.42
Altman-Z	8.72

F-Score5

WACC10.5%

ROIC/WACCN/A

Cap/Depr(3y)97.27%

Cap/Depr(5y)157.57%

Cap/Sales(3y)54.64%

Cap/Sales(5y)58.11%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)145.17%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%500%

EPS Next Y720.19%

EPS Next 2Y432.1%

EPS Next 3Y78.85%

EPS Next 5YN/A

Revenue 1Y (TTM)4.47%

Revenue growth 3Y-18.07%

Revenue growth 5Y31.59%

Sales Q2Q%41.47%

Revenue Next Year187.08%

Revenue Next 2Y101.53%

Revenue Next 3Y53.13%

Revenue Next 5YN/A

EBIT growth 1Y-98.15%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year350.81%

EBIT Next 3Y65.08%

EBIT Next 5YN/A

FCF growth 1Y-313.96%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-33.66%

OCF growth 3Y-36.92%

OCF growth 5Y84.91%

HIVE DIGITAL TECHNOLOGIES LT (HIVE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens